Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 943 of 1,261
  1. US 8071807

    Antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  2. US 8071645

    Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors

    The Regents of the University of Colorado · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  3. US 8071638

    Solid states of atorvastatin potassium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  4. US 8071692

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  5. US 8071678

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  6. US 8071603

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  7. US 8071564

    Regulation of angiogenesis with zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  8. US 8071556

    Peptide substance revealing a stress protective effect, pharmaceutical composition on its base, and the method of its application

    Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  9. US 8071535

    Guanidinium derivatives for improved cellular transport

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  10. US 8071380

    Skeletal muscle periangioblasts and cardiac mesangioblasts, method for isolation and uses thereof

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  11. US 2011293661

    VACCINE STRAINS OF BRACHYSPIRA HYODYSENTERIAE

    HAMPSON DAVID J [AU] · Granted Dec 1, 2011 · Expires Nov 26, 2031

    granted
  12. US 8067030

    Controlled release composition and method of producing the same

    Takeda Pharmaceutical Company Limited · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  13. US 8067505

    Method of preparing carboxylic acid functionalized polymers

    Nektar Therapeutics · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  14. US 8067439

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  15. US 8067416

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  16. US 8067417

    Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  17. US 8067636

    Dihydrazide compounds, preparation and uses thereof

    Bioregen Biomedical (Shanghai) Co., Ltd · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  18. US 8067445

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  19. US 8067606

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  20. US 8066985

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  21. US 8067355

    Benefit agent containing delivery particles

    Appleton Papers Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  22. US 8067219

    Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide

    Xenon Pharmaceuticals Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  23. US 8067089

    Cationic microcapsule particles

    Appleton Papers Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  24. US 8067202

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.